logo

TMO

Thermo Fisher·NYSE
--
--(--)
--
--(--)

TMO fundamentals

Thermo Fisher (TMO) released its earnings on Jan 29, 2026: revenue was 12.21B (YoY +7.20%), beat estimates; EPS was 6.57 (YoY +7.70%), beat estimates.
Revenue / YoY
12.21B
+7.20%
EPS / YoY
6.57
+7.70%
Report date
Jan 29, 2026
TMO Earnings Call Summary for Q4,2025
  • Revenue Growth: 2025 Q4 $12.21B (+7%), full-year $44.56B (+4%). 2026 guidance $46.3B-$47.2B (+4%-6%).
  • EPS Expansion: 2025 adjusted EPS $22.87 (+5%). 2026 target $24.22-$24.80 (+6%-8%).
  • Strategic Acquisitions: $13B 2025 M&A, 2026 Clario deal ($9B) for clinical data solutions.
  • Biopharma Momentum: Pharma services U.S. manufacturing expansion, clinical research AI integration.
  • AI & Wet Lab: No instrumentation displacement; AI accelerates drug discovery without reducing lab activity.
EPS
Revenue

Revenue & Expenses

TMO has released its 2025 Q4 earnings report, with revenue of 12.21B, reflecting a YoY change of 7.20%, and net profit of 1.97B, showing a YoY change of 8.00%. The Sankey diagram below clearly presents TMO's revenue sources and cost distribution.

Key Indicators

Thermo Fisher (TMO) key financial stats and ratios, covering profitability, financial health, and leverage.
Thermo Fisher (TMO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Thermo Fisher (TMO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Thermo Fisher (TMO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Thermo Fisher (TMO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Thermo Fisher (TMO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield